.png)
- healthcarenewschan
HEXOSKIN RECEIVES 2022 INTERNATIONAL SPACE STATION RESEARCH INNOVATION AWARD
Published July 28, 2022
HEXOSKIN RECEIVES 2022 INTERNATIONAL SPACE STATION RESEARCH INNOVATION AWARD FOR HUMAN HEALTH IN SPACE FROM AMERICAN ASTRONAUTICAL SOCIETY
Linked in Article by: Pierre-Alexandre Fournier
We're honored to have received the International Space Station Research Innovation Award for Human Health in Space today from the American Astronautical Society! 🚀 🌎
We received the award for the Astroskin Bio-Monitor physiology monitoring system used in research and in situ crew care aboard the International Space Station National Laboratory.
The Astroskin Bio-Monitor System was launched with SpaceX mission CRS-16 in December 2018 and was commissioned by Canadian astronaut David Saint-Jacques in January 2019. It is currently used in two clinical trials in microgravity to improve our understanding of cardiovascular health in space and physiological models of aging. These studies will help support human health during long-term space missions beyond Earth's orbit: to the Moon, Mars, and beyond.
This award also celebrates 10 years of collaboration between Hexoskin and space agencies, and a technology that has a real impact on medical research in space and in our communities.
About Astroskin: hexoskin.com/astroskin
Learn more: https://lnkd.in/e5KuhSm3
#space#medical#research#cardiovascular#pulmonary#clinicaltrials
Canadian Space Agency | Agence spatiale canadienne
Boeing Defense, Space & Security